Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
Description
CONCLUSIONS AND RELEVANCE: Higher doses of pulse methylprednisolone (500 or 1,000 mg/d) may be associated with worse COVID-19 outcomes when compared with dexamethasone, especially in patients not on IMV.
